Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Mounjaro, Zepbound shortage eases
Mounjaro, Zepbound shortage eases as supplies of weight loss drug rebound
Eli Lilly's weight-loss drug Zepbound and diabetes medication Mounjaro are no longer in short supply. That could limit cheaper copycat versions.
FDA says shortage of popular diabetes, weight-loss drugs resolved
The FDA says the shortage of tirzepatide injection — a glucagon-like peptide 1 medication used for diabetes and weight loss — has been resolved.
Shortage of Eli Lilly’s Weight-Loss, Diabetes Drugs Is Over
The FDA declared the end to shortages of Zepbound and Mounjaro. That could mean new restrictions on pharmacies making custom-made versions.
Lilly weight-loss drug copycats dealt blow as shortage ends
Eli Lilly and Co.’s blockbuster weight-loss and diabetes drugs are no longer considered to be in shortage in the US, threatening to upend the many knockoffs.
Eli Lilly’s Weight-Loss Drugs No Longer in Shortage. Bad News for Hims & Hers.
Blockbuster drugs Zepbound and Mounjaro have come off the FDA's shortage list. Shares of Hims & Hers, which had capitalized on the pinch, are tumbling.
US FDA says Lilly's weight-loss drug no longer in shortage
Eli Lilly's weight-loss drug Zepbound and diabetes drug Mounjaro are no longer in shortage, the U.S. Food and Drug Administration's website showed on Wednesday. As products move through the supply chain,
NHS, Mounjaro
NHS to roll out Mounjaro weight loss jab to 1.6 million patients
In a phased rollout, the jabs eventually will be offered to those with a BMI of 35 or more and weight-related health problems
Weight-loss jabs offered to over a million NHS patients for first time
Weight-loss jabs will be rolled out across the NHS for the first time in an effort to tackle obesity. Health officials have announced plans to offer injections of Mounjaro - the most effective on the market - to 1.
NHS leaders consider phased roll out of Mounjaro obesity jab to combat high demand
NHS leaders consider phased roll out of Mounjaro obesity jab to combat high demand - Nearly a quarter of a million people are expected to receive the Mounjaro jab over the next three years.
6h
Mounjaro and Zepbound Are No Longer in Shortage, F.D.A. Says
The change will expand access to the diabetes and weight-loss drugs. But it will also complicate the future of compounded ...
18h
Mounjaro and Zepbound no longer in shortage
After nearly two years, federal regulators announced the shortage of the active ingredient in Mounjaro and Zepbound has been ...
8h
FDA makes end of Zepbound, Mounjaro shortage official
Removal of Lilly’s in-demand drugs from the FDA’s shortage list ramps up pressure on the companies selling compounded ...
FiercePharma
4h
NHS England proposes phased rollout for Eli Lilly's star obesity drug
While Mounjaro was cleared for use in England last year, Lilly put its launch on hold until its pre-filled injection device, ...
10h
England’s NHS to Offer Eli Lilly Obesity Drug to Some Patients
Nearly 250,000 people in England could be taking Eli Lilly & Co.’s blockbuster weight-loss drug Mounjaro within three years ...
1h
Facebook has become the place to sell leftover Ozempic, other weight loss drugs — as NYC sellers take advantage of shortages and high prices
"God knows what volume they're actually selling. And who knows? You're just taking it," one expert told The Post.
FiercePharma
8h
Eli Lilly's shortage of diabetes and obesity drugs is over, halting competition with knock-offs
Eli Lilly’s juggernaut diabetes and obesity drugs Mounjaro and Zepbound have been erased from the FDA’s shortage list, ...
Daily Mail
1h
More than 1.6 million Brits set to get 'King Kong' of fat-busting jabs for free on the NHS
More than 1.6 million Britons are set to get the ‘King Kong’ of fat jabs on the NHS over the next 12 years.
Mounjaro
– ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Zepbound
Eli Lilly
United States
Food and Drug Administration
Ozempic
Feedback